Suzhou, China · Founded 2025 · Privately Held (backing)
Developer of a proprietary extrahepatic drug delivery platform designed to advance targeted small nucleic acid therapies beyond hepatic tissues. Weicheng Pharmaceuticals is based in Suzhou, China and was founded in 2025. It has raised $64 million.
Last price · $/share
—
Implied valuation
—
Total raised
$64.0M
Last round
—
Cap table — not yet on record
Weicheng Pharmaceuticals's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
